HLA Typing Market

The report "HLA Typing Market by Technology (PCR (SSO, SSP, Real-time), Sequencing (NGS, Sanger's)), Product (Instruments, Reagents, Software), Application (Donor-recipient Cross-matching, Transfusion, Cancer), End User (Hospitals, Reference Labs) Global Forecasts to 2030 ", is projected to reach USD 2.3 billion by 2030 from USD 1.7 billion in 2025, at a CAGR of 6.0% during the forecast period of 2025 to 2030. HLA typing has grown as organ transplants have increased over the last 20 years. Transplants often lead to good results for kids and young adults. The rising number of older patients with multiple health issues is making things more complicated. Kidney transplants, for example, help people live longer than long-term dialysis. Even though more solid organ transplants are occurring worldwide, there is still an insufficient supply to meet the demand.

Browse 254 market data Tables and 54 Figures spread through 266 Pages and in-depth TOC on "HLA Typing Market by Technology (PCR (SSO, SSP, Real-time), Sequencing (NGS, Sanger's)), Product (Instruments, Reagents, Software), Application (Donor-recipient Cross-matching, Transfusion, Cancer), End User (Hospitals, Reference Labs) Global Forecasts to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/hla-typing-market-39129877.html

The reagents & consumables segment is expected to register a significant growth rate during the forecast period.

The reagents & consumables segment dominated the HLA typing market. Increasing emphasis on organ, tissue, and stem cell transplants is driving the demand for precise Human Leukocyte Antigen (HLA) matching considerably. This, in turn, is fueling enhanced use of reagents and consumables required for molecular and serological testing processes. As more frequent and sophisticated transplant procedures become the norm, laboratories are increasing their testing volumes, further driving the need for high-quality diagnostic materials. Also, advances in precision medicine and donor-recipient compatibility protocols are strengthening the dependency on these consumables.

The diagnostic applications segment is expected to lead the market based on the application segment during the forecast period.

Diagnostic applications require accurate immune compatibility testing and individually tailored treatment regimens, where HLA typing becomes relevant to appreciating host-pathogen interactions, disease susceptibility prediction, and vaccine design. Increased screening programs and molecular diagnostic methods are the direct outcomes of the emerging infectious disease burden worldwide, resulting in the necessity for precise, high-throughput, and accurate HLA typing technology within clinical practice.

North America is expected to account for the largest share of the HLA typing market in 2025.

The North American HLA typing market is developing vigorously due to some major drivers. One of the most important drivers of the growth of the market is the increasing need for stem cell and organ transplants that require precise HLA matching to successfully use them. The increasing incidence of genetic disorders and autoimmune conditions has also fueled the demand for reliable diagnostic and compatibility testing products. Extensive government investments, favorable transplantation policies, and availability of research-centric healthcare facilities are also driving the market forward. The increasing use of molecular diagnostic technology and increased awareness of the concept of personalized medicine are also driving the application of HLA typing technology in clinical and research applications.

As of 2024, the key players operating in the global HLA  typing market are Becton, Dickinson and Company (US), Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), Bruker (US), and F. Hoffmann-La Roche Ltd  (Switzerland), among others.

Don’t miss out on business opportunities in HLA Typing Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/